Observing infections after bladder removal surgery
Infectious Complications After Cystectomy: A Prospective Observational Study
This study looks at how often infections happen after bladder removal surgery in patients with bladder cancer or other conditions to better understand their recovery experiences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Ludwig-Maximilians - University of Munich Academic / other |
| Locations | 1 site (Munich, Outside U.S./Canada) |
| Trial ID | NCT05153694 on ClinicalTrials.gov |
What this trial studies
This observational study enrolls patients undergoing cystectomy for bladder cancer or other reasons to evaluate the incidence of infectious complications. It collects comprehensive medical histories and documents clinicopathological parameters, along with serial measurements of infectious markers before and after surgery. In-hospital complications are recorded, and long-term outcomes are assessed through structured follow-up interviews at 3, 6, and 12 months, focusing on both clinical outcomes and patient-reported experiences.
Who should consider this trial
Good fit: Ideal candidates are patients requiring cystectomy due to bladder cancer or other medical conditions.
Not a fit: Patients who do not wish to participate or do not require bladder removal surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of infection risks and enhance post-operative care for patients undergoing cystectomy.
How similar studies have performed: Other studies have explored post-operative infections, but this specific approach focusing on interleukin-6 and patient-reported outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Disease which requires removal of the urinary bladder Exclusion Criteria: * Patient does not want to participate
Where this trial is running
Munich, Outside U.S./Canada
- Urology Department - LMU Klinikum — Munich, Outside U.S./Canada, Germany (Recruiting)
Study contacts
- Principal investigator: Gerald Schulz, PD Dr. — Ludwig-Maximilians - University of Munich
- Study coordinator: Benedikt Ebner, Dr.
- Email: Benedikt.Ebner@med.uni-muenchen.de
- Phone: 004917655197898
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.